• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

临床菌株中另一种新O抗原O86的结构与血清学特征

Structural and Serological Characterization of Yet Another New O Antigen, O86, in Clinical Strains.

作者信息

Drzewiecka Dominika, Levina Evgeniya A, Shashkov Alexander S, Kalinchuk Nadezhda A, Knirel Yuriy A

机构信息

Department of Biology of Bacteria, Faculty of Biology and Environmental Protection, University of Lodz, 90-237 Lodz, Poland.

N. D. Zelinsky Institute of Organic Chemistry, Russian Academy of Sciences, 119991 Moscow, Russia.

出版信息

Int J Mol Sci. 2024 Dec 20;25(24):13642. doi: 10.3390/ijms252413642.

DOI:10.3390/ijms252413642
PMID:39769403
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11728032/
Abstract

Bacteria from the genus are facultative human pathogens, primarily attacking the urinary tract and wounds. A total of 85 O serogroups have been identified so far among these bacilli. Bprz 86 was isolated from the fistula of a patient in Łódź, Poland. Enzyme-Linked Immunosorbent Assay (ELISA) and Western blotting studies involving the Bprz 86 lipopolysaccharide (LPS) and the strain-specific rabbit antiserum indicated that the strain, which does not belong to any of the O1-O85 serogroups, shares a common epitope with O17 antigens and is identical to another clinical strain, Sm 120, isolated from the urine of a patient in the area. The O-specific polysaccharide (O antigen) was obtained from Bprz 86 LPS through mild acid degradation, and the six-constituent structure of its repeating unit was determined using chemical analyses and 1D and 2D H and C Nuclear Magnetic Resonance (NMR) spectroscopy. It includes ()-3-hydroxybutanoyl, which, along with fucosamine and glucose residues, forms a fragment also present in the O17 antigens. Based on the obtained serological and chemical data, the two studied isolates were proposed as candidates for a new successive O serogroup in the genus , O86.

摘要

该属细菌是兼性人类病原体,主要侵袭泌尿道和伤口。迄今为止,在这些杆菌中已鉴定出总共85个O血清群。Bprz 86是从波兰罗兹一名患者的瘘管中分离出来的。涉及Bprz 86脂多糖(LPS)和菌株特异性兔抗血清的酶联免疫吸附测定(ELISA)和蛋白质印迹研究表明,该菌株不属于O1 - O85血清群中的任何一个,与O17抗原具有共同表位,并且与从该地区一名患者尿液中分离出的另一临床菌株Sm 120相同。通过温和酸降解从Bprz 86 LPS中获得O特异性多糖(O抗原),并使用化学分析以及一维和二维氢和碳核磁共振(NMR)光谱确定其重复单元的六组分结构。它包括()-3-羟基丁酰基,其与岩藻糖胺和葡萄糖残基一起形成O17抗原中也存在的一个片段。基于获得的血清学和化学数据,所研究的两种分离株被提议作为该属中一个新的连续O血清群O86的候选者。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0017/11728032/9b9cfd536ab7/ijms-25-13642-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0017/11728032/5361de62048f/ijms-25-13642-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0017/11728032/411014b459de/ijms-25-13642-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0017/11728032/9b9cfd536ab7/ijms-25-13642-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0017/11728032/5361de62048f/ijms-25-13642-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0017/11728032/411014b459de/ijms-25-13642-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0017/11728032/9b9cfd536ab7/ijms-25-13642-g003.jpg

相似文献

1
Structural and Serological Characterization of Yet Another New O Antigen, O86, in Clinical Strains.临床菌株中另一种新O抗原O86的结构与血清学特征
Int J Mol Sci. 2024 Dec 20;25(24):13642. doi: 10.3390/ijms252413642.
2
Structure and serological properties of the O-antigen of two clinical Proteus mirabilis strains classified into a new Proteus O77 serogroup.两株临床奇异变形杆菌菌株的O抗原结构和血清学特性,这两株菌株被归类为一个新的变形杆菌O77血清群。
FEMS Immunol Med Microbiol. 2008 Nov;54(2):185-94. doi: 10.1111/j.1574-695X.2008.00462.x. Epub 2008 Jul 28.
3
Structural and serological characterization of the O82 antigen of a Proteus mirabilis strain isolated from a patient in Poland.波兰分离株奇异变形杆菌 O82 抗原的结构和血清学特征。
Carbohydr Res. 2019 Dec 1;486:107831. doi: 10.1016/j.carres.2019.107831. Epub 2019 Oct 7.
4
Immunochemical characterization of the O antigens of two Proteus strains, O8-related antigen of Proteus mirabilis 12 B-r and O2-related antigen of Proteus genomospecies 5/6 12 B-k, infecting a hospitalized patient in Poland.对两株变形杆菌菌株O抗原的免疫化学特性分析,即奇异变形杆菌12 B-r的O8相关抗原和基因组种5/6变形杆菌12 B-k的O2相关抗原,该菌株感染了一名波兰住院患者。
Microbiology (Reading). 2016 May;162(5):789-797. doi: 10.1099/mic.0.000274. Epub 2016 Mar 9.
5
Structural and Serological Characterization of the O Antigen of Clinical Isolates Classified into a New Serogroup, O84.临床分离株 O 抗原的结构和血清学特征,这些分离株被归入一个新的血清群,O84。
Int J Mol Sci. 2023 Feb 28;24(5):4699. doi: 10.3390/ijms24054699.
6
Serotyping of Proteus mirabilis clinical strains based on lipopolysaccharide O-polysaccharide and core oligosaccharide structures.基于脂多糖 O-多糖和核心寡糖结构对奇异变形杆菌临床分离株进行血清分型。
Biochemistry (Mosc). 2011 Jul;76(7):851-61. doi: 10.1134/S0006297911070169.
7
Antigenic and Structural Properties of the Lipopolysaccharide of the Uropathogenic Dm55 Strain Classified to a New O85 Serogroup.具有抗原性和结构特性的尿路致病性 Dm55 菌株的脂多糖,该菌株被分类到一个新的 O85 血清群。
Int J Mol Sci. 2023 Nov 16;24(22):16424. doi: 10.3390/ijms242216424.
8
Chemical characterization and serological properties of a unique O-polysaccharide of the Proteus mirabilis Sm 99 clinical strain - Identification of a new, O81, serotype.奇异变形杆菌 Sm 99 临床分离株独特 O-多糖的化学特征和血清学性质-鉴定一个新的 O81 血清型。
Int J Biol Macromol. 2018 Oct 15;118(Pt A):1131-1135. doi: 10.1016/j.ijbiomac.2018.06.174. Epub 2018 Jul 2.
9
Structural and serological studies of the O-polysaccharide of strains from a newly created Proteus O78 serogroup prevalent in Polish patients.对波兰患者中流行的新创建的变形杆菌O78血清群菌株的O-多糖进行的结构和血清学研究。
FEMS Immunol Med Microbiol. 2010 Mar;58(2):269-76. doi: 10.1111/j.1574-695X.2009.00632.x. Epub 2009 Nov 11.
10
Structures and serology of the O-antigens of Proteus strains classified into serogroup O17 and former serogroup O35.分类为O17血清群和原O35血清群的变形杆菌菌株O抗原的结构与血清学
Arch Immunol Ther Exp (Warsz). 2006 Jul-Aug;54(4):277-82. doi: 10.1007/s00005-006-0031-1. Epub 2006 Jul 25.

引用本文的文献

1
The First Report on the Structure of Polysaccharide Surface Antigens of the Clinical 0.062 Strain and the Contribution in the Serological Cross-Reactions.临床0.062菌株多糖表面抗原结构的首次报告及其在血清学交叉反应中的作用。
Int J Mol Sci. 2025 Mar 29;26(7):3177. doi: 10.3390/ijms26073177.

本文引用的文献

1
Lipopolysaccharide as a Vaccine Target and the Role of Antibodies in Protection from Disease.脂多糖作为疫苗靶点及抗体在预防疾病中的作用。
Vaccines (Basel). 2024 Oct 17;12(10):1177. doi: 10.3390/vaccines12101177.
2
Current state and novel outlook on prevention and treatment of rising antibiotic resistance in urinary tract infections.当前尿路感染中抗生素耐药性上升的预防和治疗的现状和新展望。
Pharmacol Ther. 2024 Sep;261:108688. doi: 10.1016/j.pharmthera.2024.108688. Epub 2024 Jul 6.
3
Antigenic and Structural Properties of the Lipopolysaccharide of the Uropathogenic Dm55 Strain Classified to a New O85 Serogroup.
具有抗原性和结构特性的尿路致病性 Dm55 菌株的脂多糖,该菌株被分类到一个新的 O85 血清群。
Int J Mol Sci. 2023 Nov 16;24(22):16424. doi: 10.3390/ijms242216424.
4
A Novel O-Polysaccharide-IpaB Conjugate Vaccine Elicits Robust Antibody Responses and Confers Protection against Multiple Serotypes.一种新型 O-多糖-IpaB 缀合疫苗可诱导强烈的抗体应答,并针对多种血清型提供保护。
mSphere. 2023 Jun 22;8(3):e0001923. doi: 10.1128/msphere.00019-23. Epub 2023 Apr 5.
5
The Development of Immunological Assays to Evaluate the Level and Function of Antibodies Induced by Klebsiella pneumoniae O-Antigen Vaccines.评估肺炎克雷伯菌 O 抗原疫苗诱导的抗体水平和功能的免疫分析方法的研究进展。
mSphere. 2023 Apr 20;8(2):e0068022. doi: 10.1128/msphere.00680-22. Epub 2023 Mar 6.
6
Evaluation of antibiotic resistance in Proteus spp: a growing trend that worries Public Health. Results of 10 Years of Analysis.探讨变形杆菌属的抗生素耐药性:公共卫生令人担忧的新趋势。10 年分析结果。
New Microbiol. 2022 Dec;45(4):269-277. Epub 2022 Oct 3.
7
Into the understanding the multicellular lifestyle of on solid surfaces.深入理解生物在固体表面的多细胞生活方式。
Front Cell Infect Microbiol. 2022 Sep 2;12:864305. doi: 10.3389/fcimb.2022.864305. eCollection 2022.
8
Preclinical Immunogenicity and Efficacy of Optimized O25b O-Antigen Glycoconjugates To Prevent MDR ST131 E. coli Infections.优化 O25bO-抗原糖缀合物的临床前免疫原性和功效,以预防 MDR ST131 大肠杆菌感染。
Infect Immun. 2022 Apr 21;90(4):e0002222. doi: 10.1128/iai.00022-22. Epub 2022 Mar 21.
9
Serum levels of immunoglobulin and complement in UTI of patients caused by Proteus mirabilis and using AgNPs as antiswarming.变形杆菌引起的尿路感染患者血清免疫球蛋白和补体水平及 AgNPs 抗聚集作用
Cell Mol Biol (Noisy-le-grand). 2021 Nov 25;67(3):11-23. doi: 10.14715/cmb/2021.67.3.3.
10
The prevailing O serogroups among the serologically differentiated clinical Proteus spp. strains in central Poland.在波兰中部,经血清学分型的临床变形杆菌属分离株中流行的 O 血清群。
Sci Rep. 2021 Sep 23;11(1):18982. doi: 10.1038/s41598-021-98228-w.